Be Biopharma
MA - CambridgePharmaceutical
Focus: Be Biopharma is a newly founded (2023) biotech company focused on engineered B cell therapies for rare diseases, based in Cambridge, MA. The company is pre-clinical to early-stage with a single Phase 1/2 program targeting hemophilia B.
Profile data last refreshed 16h ago · AI intelligence enriched 2w ago
Open Jobs
5+4 this month
Stable — net +4 jobs in 30d
11 added, 7 removed. Backfill posture.
Should You Work at Be Biopharma?
AI assessmentHigh-upside opportunity for risk-tolerant scientists seeking early-stage discovery work in novel cell therapy, but requires comfort with funding uncertainty and limited institutional infrastructure.
Why Work Here
- Join a cutting-edge platform company in engineered B cells, an emerging modality with significant differentiation potential in rare disease immunology.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Growing
Jobs increasing
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
BE-101
Hemophilia BClinical Trials (1)
NCT06611436BeCoMe-9: A Clinical Study of BE-101 for the Treatment of Adults With Moderately Severe or Severe Hemophilia B
Phase 1/2Help build intelligence for Be Biopharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.